Treatment outcome of pneumonia due to carbapenem-resistant Acinetobacter baumannii complex

被引：0

作者：

Choi, W. S. ^{[1
]}

Lee, S. ^{[2
,3
]}

Moon, C. ^{[4
]}

Park, D. W. ^{[1
]}

Song, J. Y. ^{[1
]}

Cheong, H. J. ^{[1
]}

Kim, J. ^{[5
]}

Kim, J. Y. ^{[6
]}

Park, M. N. ^{[7
]}

Kim, Y. R. ^{[8
]}

Lee, H. -J. ^{[8
]}

Kim, B. ^{[9
]}

Pai, H. ^{[5
]}

Jo, Y. M. ^{[1
]}

Kim, J. H. ^{[1
]}

Sohn, J. W. ^{[1
]}

机构：

[1] Dept Internal Med, Div Infect Dis, Seoul, South Korea

[2] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea

[3] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea

[4] Inje Univ, Busan Paik Hosp, Div Infect Dis, Busan, South Korea

[5] Hanyang Univ, Coll Med, Div Infect Dis, Seoul, South Korea

[6] Incheon Med Ctr, Dept Internal Med, Incheon, South Korea

[7] Incheon Med Ctr, Infect Control Off, Incheon, South Korea

[8] Catholic Univ Korea, Div Infect Dis, Dept Internal Med, Coll Med, Seoul, South Korea

[9] Eulji Univ, Coll Med, Div Infect Dis, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

P2-LB22

引用

页码：S156 / S157

页数：2

共 50 条

[1] Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Franzone, John P.
Mackow, Natalie A.
van Duin, David
CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (02) : 137 - 143
[2] Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
Shi, HyeJin
Lee, Jin Seo
Park, So Yeon
Ko, Yousang
Eom, Joong Sik
INFECTION AND DRUG RESISTANCE, 2019, 12 : 3925 - 3934
[3] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
Piperaki, E. -T.
Tzouvelekis, L. S.
Miriagou, V.
Daikos, G. L.
CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 951 - 957
[4] Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia
Park, Seong Yeon
Lee, Eun Jung
Kim, Tark
Yu, Shi Nae
Park, Ki-Ho
Lee, Mi Suk
Park, Se Yoon
Jeon, Min Hyok
Kim, Tae Hyong
Choo, Eun Ju
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (03) : 407 - 412
[5] Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
Zhang, Siqin
Di, Lingfang
Qi, Yan
Qian, Xiang
Wang, Siwei
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
[6] Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections
Iovleva, Alina
Fowler Jr, Vance G.
Doi, Yohei
DRUGS, 2025, 85 (01) : 21 - 40
[7] The Rise of Carbapenem-Resistant Acinetobacter baumannii
Evans, Benjamin A.
Hamouda, Ahmed
Amyes, Sebastian G. B.
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
[8] Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
Kwon, Ki Hwan
Oh, Jin Young
Yoon, Young-Soon
Jeong, Yun-Jeong
Kim, Kyung Soo
Shin, Sung Joon
Chung, Jae Woo
Huh, Hee Jin
Chae, Seok Lae
Park, Seong Yeon
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (06) : 605 - 609
[9] CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
Akers, Kevin S.
Barsoumian, Alice
Beckius, Miriam L.
Murray, Clinton K.
Mende, Katrin
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 67 (02) : 209 - 211
[10] Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia
Garnacho-Montero, Jose
Amaya-Villar, Rosario
Ferrandiz-Millon, Carmen
Diaz-Martin, Ana
Maria Lopez-Sanchez, Jose
Gutierrez-Pizarraya, Antonio
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (06) : 769 - 777

← 1 2 3 4 5 →